(1S,5R)-N-[8-amino-6-(2-methylphenyl)-2,7-naphthyridin-3-yl]-3-(3-methoxyazetidin-1-yl)bicyclo[3.1.0]hexane-6-carboxamide;(1S,5R)-N-[8-amino-6-(2-methylphenyl)-2,7-naphthyridin-3-yl]-3-morpholin-4-ylbicyclo[3.1.0]hexane-6-carboxamide;trans-(1R,2R)-N-[8-amino-6-(2,6-dichlorophenyl)-2,7-naphthyridin-3-yl]-2-[1-[2-(2-aminoethoxy)ethyl]pyrazol-4-yl]cyclopropane-1-carboxamide;trans-(1S,2S)-N-[8-amino-6-(2,6-dichlorophenyl)-2,7-naphthyridin-3-yl]-2-[1-[2-(2-aminoethoxy)ethyl]pyrazol-4-yl]cyclopropane-1-carboxamide;trans-(1R,2R)-2-[1-[2-(2-aminoethoxy)ethyl]pyrazol-4-yl]-N-[8-amino-6-(2-methylphenyl)-2,7-naphthyridin-3-yl]cyclopropane-1-carboxamide

C128H137Cl4N31O10 — CID 159579966

IUPAC(1S,5R)-N-[8-amino-6-(2-methylphenyl)-2,7-naphthyridin-3-yl]-3-(3-methoxyazetidin-1-yl)bicyclo[3.1.0]hexane-6-carboxamide;(1S,5R)-N-[8-amino-6-(2-methylphenyl)-2,7-naphthyridin-3-yl]-3-morpholin-4-ylbicyclo[3.1.0]hexane-6-carboxamide;trans-(1R,2R)-N-[8-amino-6-(2,6-dichlorophenyl)-2,7-naphthyridin-3-yl]-2-[1-[2-(2-aminoethoxy)ethyl]pyrazol-4-yl]cyclopropane-1-carboxamide;trans-(1S,2S)-N-[8-amino-6-(2,6-dichlorophenyl)-2,7-naphthyridin-3-yl]-2-[1-[2-(2-aminoethoxy)ethyl]pyrazol-4-yl]cyclopropane-1-carboxamide;trans-(1R,2R)-2-[1-[2-(2-aminoethoxy)ethyl]pyrazol-4-yl]-N-[8-amino-6-(2-methylphenyl)-2,7-naphthyridin-3-yl]cyclopropane-1-carboxamide
SMILESCOC1CN(C2C[C@@H]3C(C(=O)Nc4cc5cc(-c6ccccc6C)nc(N)c5cn4)[C@@H]3C2)C1.Cc1ccccc1-c1cc2cc(NC(=O)C3[C@H]4CC(N5CCOCC5)C[C@@H]34)ncc2c(N)n1.Cc1ccccc1-c1cc2cc(NC(=O)[C@@H]3C[C@H]3c3cnn(CCOCCN)c3)ncc2c(N)n1.NCCOCCn1cc([C@@H]2C[C@H]2C(=O)Nc2cc3cc(-c4c(Cl)cccc4Cl)nc(N)c3cn2)cn1.NCCOCCn1cc([C@H]2C[C@@H]2C(=O)Nc2cc3cc(-c4c(Cl)cccc4Cl)nc(N)c3cn2)cn1
InChIInChI=1S/C26H29N7O2.2C26H29N5O2.2C25H25Cl2N7O2/c1-16-4-2-3-5-19(16)23-10-17-11-24(29-14-22(17)25(28)31-23)32-26(34)21-12-20(21)18-13-30-33(15-18)7-9-35-8-6-27;1-14-5-3-4-6-18(14)22-7-15-8-23(28-11-21(15)25(27)29-22)30-26(32)24-19-9-16(10-20(19)24)31-12-17(13-31)33-2;1-15-4-2-3-5-18(15)22-10-16-11-23(28-14-21(16)25(27)29-22)30-26(32)24-19-12-17(13-20(19)24)31-6-8-33-9-7-31;2*26-19-2-1-3-20(27)23(19)21-8-14-9-22(30-12-18(14)24(29)32-21)33-25(35)17-10-16(17)15-11-31-34(13-15)5-7-36-6-4-28/h2-5,10-11,13-15,20-21H,6-9,12,27H2,1H3,(H2,28,31)(H,29,32,34);3-8,11,16-17,19-20,24H,9-10,12-13H2,1-2H3,(H2,27,29)(H,28,30,32);2-5,10-11,14,17,19-20,24H,6-9,12-13H2,1H3,(H2,27,29)(H,28,30,32);2*1-3,8-9,11-13,16-17H,4-7,10,28H2,(H2,29,32)(H,30,33,35)/t20-,21+;16?,19-,20+,24?;17?,19-,20+,24?;2*16-,17+/m0..10/s1
InChIKeyMIWVWMXVYLYQSJ-PFIWMCNESA-N
MW2411.52 g/mol
LogP18.26
Rot. Bonds36

About (1S,5R)-N-[8-amino-6-(2-methylphenyl)-2,7-naphthyridin-3-yl]-3-(3-methoxyazetidin-1-yl)bicyclo[3.1.0]hexane-6-carboxamide;(1S,5R)-N-[8-amino-6-(2-methylphenyl)-2,7-naphthyridin-3-yl]-3-morpholin-4-ylbicyclo[3.1.0]hexane-6-carboxamide;trans-(1R,2R)-N-[8-amino-6-(2,6-dichlorophenyl)-2,7-naphthyridin-3-yl]-2-[1-[2-(2-aminoethoxy)ethyl]pyrazol-4-yl]cyclopropane-1-carboxamide;trans-(1S,2S)-N-[8-amino-6-(2,6-dichlorophenyl)-2,7-naphthyridin-3-yl]-2-[1-[2-(2-aminoethoxy)ethyl]pyrazol-4-yl]cyclopropane-1-carboxamide;trans-(1R,2R)-2-[1-[2-(2-aminoethoxy)ethyl]pyrazol-4-yl]-N-[8-amino-6-(2-methylphenyl)-2,7-naphthyridin-3-yl]cyclopropane-1-carboxamide

(1S,5R)-N-[8-amino-6-(2-methylphenyl)-2,7-naphthyridin-3-yl]-3-(3-methoxyazetidin-1-yl)bicyclo[3.1.0]hexane-6-carboxamide;(1S,5R)-N-[8-amino-6-(2-methylphenyl)-2,7-naphthyridin-3-yl]-3-morpholin-4-ylbicyclo[3.1.0]hexane-6-carboxamide;trans-(1R,2R)-N-[8-amino-6-(2,6-dichlorophenyl)-2,7-naphthyridin-3-yl]-2-[1-[2-(2-aminoethoxy)ethyl]pyrazol-4-yl]cyclopropane-1-carboxamide;trans-(1S,2S)-N-[8-amino-6-(2,6-dichlorophenyl)-2,7-naphthyridin-3-yl]-2-[1-[2-(2-aminoethoxy)ethyl]pyrazol-4-yl]cyclopropane-1-carboxamide;trans-(1R,2R)-2-[1-[2-(2-aminoethoxy)ethyl]pyrazol-4-yl]-N-[8-amino-6-(2-methylphenyl)-2,7-naphthyridin-3-yl]cyclopropane-1-carboxamide (PubChem CID 159579966) has the molecular formula C128H137Cl4N31O10 and a molecular weight of 2411.52 g/mol. Its IUPAC name is (1S,5R)-N-[8-amino-6-(2-methylphenyl)-2,7-naphthyridin-3-yl]-3-(3-methoxyazetidin-1-yl)bicyclo[3.1.0]hexane-6-carboxamide;(1S,5R)-N-[8-amino-6-(2-methylphenyl)-2,7-naphthyridin-3-yl]-3-morpholin-4-ylbicyclo[3.1.0]hexane-6-carboxamide;trans-(1R,2R)-N-[8-amino-6-(2,6-dichlorophenyl)-2,7-naphthyridin-3-yl]-2-[1-[2-(2-aminoethoxy)ethyl]pyrazol-4-yl]cyclopropane-1-carboxamide;trans-(1S,2S)-N-[8-amino-6-(2,6-dichlorophenyl)-2,7-naphthyridin-3-yl]-2-[1-[2-(2-aminoethoxy)ethyl]pyrazol-4-yl]cyclopropane-1-carboxamide;trans-(1R,2R)-2-[1-[2-(2-aminoethoxy)ethyl]pyrazol-4-yl]-N-[8-amino-6-(2-methylphenyl)-2,7-naphthyridin-3-yl]cyclopropane-1-carboxamide.

Molecular Properties

Compound Name(1S,5R)-N-[8-amino-6-(2-methylphenyl)-2,7-naphthyridin-3-yl]-3-(3-methoxyazetidin-1-yl)bicyclo[3.1.0]hexane-6-carboxamide;(1S,5R)-N-[8-amino-6-(2-methylphenyl)-2,7-naphthyridin-3-yl]-3-morpholin-4-ylbicyclo[3.1.0]hexane-6-carboxamide;trans-(1R,2R)-N-[8-amino-6-(2,6-dichlorophenyl)-2,7-naphthyridin-3-yl]-2-[1-[2-(2-aminoethoxy)ethyl]pyrazol-4-yl]cyclopropane-1-carboxamide;trans-(1S,2S)-N-[8-amino-6-(2,6-dichlorophenyl)-2,7-naphthyridin-3-yl]-2-[1-[2-(2-aminoethoxy)ethyl]pyrazol-4-yl]cyclopropane-1-carboxamide;trans-(1R,2R)-2-[1-[2-(2-aminoethoxy)ethyl]pyrazol-4-yl]-N-[8-amino-6-(2-methylphenyl)-2,7-naphthyridin-3-yl]cyclopropane-1-carboxamide
PubChem CID159579966
Molecular FormulaC128H137Cl4N31O10
Molecular Weight2411.52 g/mol
Exact Mass2407.99
IUPAC Name(1S,5R)-N-[8-amino-6-(2-methylphenyl)-2,7-naphthyridin-3-yl]-3-(3-methoxyazetidin-1-yl)bicyclo[3.1.0]hexane-6-carboxamide;(1S,5R)-N-[8-amino-6-(2-methylphenyl)-2,7-naphthyridin-3-yl]-3-morpholin-4-ylbicyclo[3.1.0]hexane-6-carboxamide;trans-(1R,2R)-N-[8-amino-6-(2,6-dichlorophenyl)-2,7-naphthyridin-3-yl]-2-[1-[2-(2-aminoethoxy)ethyl]pyrazol-4-yl]cyclopropane-1-carboxamide;trans-(1S,2S)-N-[8-amino-6-(2,6-dichlorophenyl)-2,7-naphthyridin-3-yl]-2-[1-[2-(2-aminoethoxy)ethyl]pyrazol-4-yl]cyclopropane-1-carboxamide;trans-(1R,2R)-2-[1-[2-(2-aminoethoxy)ethyl]pyrazol-4-yl]-N-[8-amino-6-(2-methylphenyl)-2,7-naphthyridin-3-yl]cyclopropane-1-carboxamide
SMILESCOC1CN(C2C[C@@H]3C(C(=O)Nc4cc5cc(-c6ccccc6C)nc(N)c5cn4)[C@@H]3C2)C1.Cc1ccccc1-c1cc2cc(NC(=O)C3[C@H]4CC(N5CCOCC5)C[C@@H]34)ncc2c(N)n1.Cc1ccccc1-c1cc2cc(NC(=O)[C@@H]3C[C@H]3c3cnn(CCOCCN)c3)ncc2c(N)n1.NCCOCCn1cc([C@@H]2C[C@H]2C(=O)Nc2cc3cc(-c4c(Cl)cccc4Cl)nc(N)c3cn2)cn1.NCCOCCn1cc([C@H]2C[C@@H]2C(=O)Nc2cc3cc(-c4c(Cl)cccc4Cl)nc(N)c3cn2)cn1
InChIInChI=1S/C26H29N7O2.2C26H29N5O2.2C25H25Cl2N7O2/c1-16-4-2-3-5-19(16)23-10-17-11-24(29-14-22(17)25(28)31-23)32-26(34)21-12-20(21)18-13-30-33(15-18)7-9-35-8-6-27;1-14-5-3-4-6-18(14)22-7-15-8-23(28-11-21(15)25(27)29-22)30-26(32)24-19-9-16(10-20(19)24)31-12-17(13-31)33-2;1-15-4-2-3-5-18(15)22-10-16-11-23(28-14-21(16)25(27)29-22)30-26(32)24-19-12-17(13-20(19)24)31-6-8-33-9-7-31;2*26-19-2-1-3-20(27)23(19)21-8-14-9-22(30-12-18(14)24(29)32-21)33-25(35)17-10-16(17)15-11-31-34(13-15)5-7-36-6-4-28/h2-5,10-11,13-15,20-21H,6-9,12,27H2,1H3,(H2,28,31)(H,29,32,34);3-8,11,16-17,19-20,24H,9-10,12-13H2,1-2H3,(H2,27,29)(H,28,30,32);2-5,10-11,14,17,19-20,24H,6-9,12-13H2,1H3,(H2,27,29)(H,28,30,32);2*1-3,8-9,11-13,16-17H,4-7,10,28H2,(H2,29,32)(H,30,33,35)/t20-,21+;16?,19-,20+,24?;17?,19-,20+,24?;2*16-,17+/m0..10/s1
InChIKeyMIWVWMXVYLYQSJ-PFIWMCNESA-N
XLogP18.26
TPSA588.65 Ų
H-Bond Donors13
H-Bond Acceptors36
Rotatable Bonds36
Heavy Atoms173
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002411.52
LogP ≤ 518.26
H-Bond Donors ≤ 513
H-Bond Acceptors ≤ 1036

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze (1S,5R)-N-[8-amino-6-(2-methylphenyl)-2,7-naphthyridin-3-yl]-3-(3-methoxyazetidin-1-yl)bicyclo[3.1.0]hexane-6-carboxamide;(1S,5R)-N-[8-amino-6-(2-methylphenyl)-2,7-naphthyridin-3-yl]-3-morpholin-4-ylbicyclo[3.1.0]hexane-6-carboxamide;trans-(1R,2R)-N-[8-amino-6-(2,6-dichlorophenyl)-2,7-naphthyridin-3-yl]-2-[1-[2-(2-aminoethoxy)ethyl]pyrazol-4-yl]cyclopropane-1-carboxamide;trans-(1S,2S)-N-[8-amino-6-(2,6-dichlorophenyl)-2,7-naphthyridin-3-yl]-2-[1-[2-(2-aminoethoxy)ethyl]pyrazol-4-yl]cyclopropane-1-carboxamide;trans-(1R,2R)-2-[1-[2-(2-aminoethoxy)ethyl]pyrazol-4-yl]-N-[8-amino-6-(2-methylphenyl)-2,7-naphthyridin-3-yl]cyclopropane-1-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (1S,5R)-N-[8-amino-6-(2-methylphenyl)-2,7-naphthyridin-3-yl]-3-(3-methoxyazetidin-1-yl)bicyclo[3.1.0]hexane-6-carboxamide;(1S,5R)-N-[8-amino-6-(2-methylphenyl)-2,7-naphthyridin-3-yl]-3-morpholin-4-ylbicyclo[3.1.0]hexane-6-carboxamide;trans-(1R,2R)-N-[8-amino-6-(2,6-dichlorophenyl)-2,7-naphthyridin-3-yl]-2-[1-[2-(2-aminoethoxy)ethyl]pyrazol-4-yl]cyclopropane-1-carboxamide;trans-(1S,2S)-N-[8-amino-6-(2,6-dichlorophenyl)-2,7-naphthyridin-3-yl]-2-[1-[2-(2-aminoethoxy)ethyl]pyrazol-4-yl]cyclopropane-1-carboxamide;trans-(1R,2R)-2-[1-[2-(2-aminoethoxy)ethyl]pyrazol-4-yl]-N-[8-amino-6-(2-methylphenyl)-2,7-naphthyridin-3-yl]cyclopropane-1-carboxamide?
The IUPAC name of (1S,5R)-N-[8-amino-6-(2-methylphenyl)-2,7-naphthyridin-3-yl]-3-(3-methoxyazetidin-1-yl)bicyclo[3.1.0]hexane-6-carboxamide;(1S,5R)-N-[8-amino-6-(2-methylphenyl)-2,7-naphthyridin-3-yl]-3-morpholin-4-ylbicyclo[3.1.0]hexane-6-carboxamide;trans-(1R,2R)-N-[8-amino-6-(2,6-dichlorophenyl)-2,7-naphthyridin-3-yl]-2-[1-[2-(2-aminoethoxy)ethyl]pyrazol-4-yl]cyclopropane-1-carboxamide;trans-(1S,2S)-N-[8-amino-6-(2,6-dichlorophenyl)-2,7-naphthyridin-3-yl]-2-[1-[2-(2-aminoethoxy)ethyl]pyrazol-4-yl]cyclopropane-1-carboxamide;trans-(1R,2R)-2-[1-[2-(2-aminoethoxy)ethyl]pyrazol-4-yl]-N-[8-amino-6-(2-methylphenyl)-2,7-naphthyridin-3-yl]cyclopropane-1-carboxamide (CID 159579966) is (1S,5R)-N-[8-amino-6-(2-methylphenyl)-2,7-naphthyridin-3-yl]-3-(3-methoxyazetidin-1-yl)bicyclo[3.1.0]hexane-6-carboxamide;(1S,5R)-N-[8-amino-6-(2-methylphenyl)-2,7-naphthyridin-3-yl]-3-morpholin-4-ylbicyclo[3.1.0]hexane-6-carboxamide;trans-(1R,2R)-N-[8-amino-6-(2,6-dichlorophenyl)-2,7-naphthyridin-3-yl]-2-[1-[2-(2-aminoethoxy)ethyl]pyrazol-4-yl]cyclopropane-1-carboxamide;trans-(1S,2S)-N-[8-amino-6-(2,6-dichlorophenyl)-2,7-naphthyridin-3-yl]-2-[1-[2-(2-aminoethoxy)ethyl]pyrazol-4-yl]cyclopropane-1-carboxamide;trans-(1R,2R)-2-[1-[2-(2-aminoethoxy)ethyl]pyrazol-4-yl]-N-[8-amino-6-(2-methylphenyl)-2,7-naphthyridin-3-yl]cyclopropane-1-carboxamide.
What is the SMILES notation for (1S,5R)-N-[8-amino-6-(2-methylphenyl)-2,7-naphthyridin-3-yl]-3-(3-methoxyazetidin-1-yl)bicyclo[3.1.0]hexane-6-carboxamide;(1S,5R)-N-[8-amino-6-(2-methylphenyl)-2,7-naphthyridin-3-yl]-3-morpholin-4-ylbicyclo[3.1.0]hexane-6-carboxamide;trans-(1R,2R)-N-[8-amino-6-(2,6-dichlorophenyl)-2,7-naphthyridin-3-yl]-2-[1-[2-(2-aminoethoxy)ethyl]pyrazol-4-yl]cyclopropane-1-carboxamide;trans-(1S,2S)-N-[8-amino-6-(2,6-dichlorophenyl)-2,7-naphthyridin-3-yl]-2-[1-[2-(2-aminoethoxy)ethyl]pyrazol-4-yl]cyclopropane-1-carboxamide;trans-(1R,2R)-2-[1-[2-(2-aminoethoxy)ethyl]pyrazol-4-yl]-N-[8-amino-6-(2-methylphenyl)-2,7-naphthyridin-3-yl]cyclopropane-1-carboxamide?
The canonical SMILES for (1S,5R)-N-[8-amino-6-(2-methylphenyl)-2,7-naphthyridin-3-yl]-3-(3-methoxyazetidin-1-yl)bicyclo[3.1.0]hexane-6-carboxamide;(1S,5R)-N-[8-amino-6-(2-methylphenyl)-2,7-naphthyridin-3-yl]-3-morpholin-4-ylbicyclo[3.1.0]hexane-6-carboxamide;trans-(1R,2R)-N-[8-amino-6-(2,6-dichlorophenyl)-2,7-naphthyridin-3-yl]-2-[1-[2-(2-aminoethoxy)ethyl]pyrazol-4-yl]cyclopropane-1-carboxamide;trans-(1S,2S)-N-[8-amino-6-(2,6-dichlorophenyl)-2,7-naphthyridin-3-yl]-2-[1-[2-(2-aminoethoxy)ethyl]pyrazol-4-yl]cyclopropane-1-carboxamide;trans-(1R,2R)-2-[1-[2-(2-aminoethoxy)ethyl]pyrazol-4-yl]-N-[8-amino-6-(2-methylphenyl)-2,7-naphthyridin-3-yl]cyclopropane-1-carboxamide is COC1CN(C2C[C@@H]3C(C(=O)Nc4cc5cc(-c6ccccc6C)nc(N)c5cn4)[C@@H]3C2)C1.Cc1ccccc1-c1cc2cc(NC(=O)C3[C@H]4CC(N5CCOCC5)C[C@@H]34)ncc2c(N)n1.Cc1ccccc1-c1cc2cc(NC(=O)[C@@H]3C[C@H]3c3cnn(CCOCCN)c3)ncc2c(N)n1.NCCOCCn1cc([C@@H]2C[C@H]2C(=O)Nc2cc3cc(-c4c(Cl)cccc4Cl)nc(N)c3cn2)cn1.NCCOCCn1cc([C@H]2C[C@@H]2C(=O)Nc2cc3cc(-c4c(Cl)cccc4Cl)nc(N)c3cn2)cn1.
What is the InChIKey of (1S,5R)-N-[8-amino-6-(2-methylphenyl)-2,7-naphthyridin-3-yl]-3-(3-methoxyazetidin-1-yl)bicyclo[3.1.0]hexane-6-carboxamide;(1S,5R)-N-[8-amino-6-(2-methylphenyl)-2,7-naphthyridin-3-yl]-3-morpholin-4-ylbicyclo[3.1.0]hexane-6-carboxamide;trans-(1R,2R)-N-[8-amino-6-(2,6-dichlorophenyl)-2,7-naphthyridin-3-yl]-2-[1-[2-(2-aminoethoxy)ethyl]pyrazol-4-yl]cyclopropane-1-carboxamide;trans-(1S,2S)-N-[8-amino-6-(2,6-dichlorophenyl)-2,7-naphthyridin-3-yl]-2-[1-[2-(2-aminoethoxy)ethyl]pyrazol-4-yl]cyclopropane-1-carboxamide;trans-(1R,2R)-2-[1-[2-(2-aminoethoxy)ethyl]pyrazol-4-yl]-N-[8-amino-6-(2-methylphenyl)-2,7-naphthyridin-3-yl]cyclopropane-1-carboxamide?
The InChIKey is MIWVWMXVYLYQSJ-PFIWMCNESA-N. The full InChI is InChI=1S/C26H29N7O2.2C26H29N5O2.2C25H25Cl2N7O2/c1-16-4-2-3-5-19(16)23-10-17-11-24(29-14-22(17)25(28)31-23)32-26(34)21-12-20(21)18-13-30-33(15-18)7-9-35-8-6-27;1-14-5-3-4-6-18(14)22-7-15-8-23(28-11-21(15)25(27)29-22)30-26(32)24-19-9-16(10-20(19)24)31-12-17(13-31)33-2;1-15-4-2-3-5-18(15)22-10-16-11-23(28-14-21(16)25(27)29-22)30-26(32)24-19-12-17(13-20(19)24)31-6-8-33-9-7-31;2*26-19-2-1-3-20(27)23(19)21-8-14-9-22(30-12-18(14)24(29)32-21)33-25(35)17-10-16(17)15-11-31-34(13-15)5-7-36-6-4-28/h2-5,10-11,13-15,20-21H,6-9,12,27H2,1H3,(H2,28,31)(H,29,32,34);3-8,11,16-17,19-20,24H,9-10,12-13H2,1-2H3,(H2,27,29)(H,28,30,32);2-5,10-11,14,17,19-20,24H,6-9,12-13H2,1H3,(H2,27,29)(H,28,30,32);2*1-3,8-9,11-13,16-17H,4-7,10,28H2,(H2,29,32)(H,30,33,35)/t20-,21+;16?,19-,20+,24?;17?,19-,20+,24?;2*16-,17+/m0..10/s1.
What are the key properties of (1S,5R)-N-[8-amino-6-(2-methylphenyl)-2,7-naphthyridin-3-yl]-3-(3-methoxyazetidin-1-yl)bicyclo[3.1.0]hexane-6-carboxamide;(1S,5R)-N-[8-amino-6-(2-methylphenyl)-2,7-naphthyridin-3-yl]-3-morpholin-4-ylbicyclo[3.1.0]hexane-6-carboxamide;trans-(1R,2R)-N-[8-amino-6-(2,6-dichlorophenyl)-2,7-naphthyridin-3-yl]-2-[1-[2-(2-aminoethoxy)ethyl]pyrazol-4-yl]cyclopropane-1-carboxamide;trans-(1S,2S)-N-[8-amino-6-(2,6-dichlorophenyl)-2,7-naphthyridin-3-yl]-2-[1-[2-(2-aminoethoxy)ethyl]pyrazol-4-yl]cyclopropane-1-carboxamide;trans-(1R,2R)-2-[1-[2-(2-aminoethoxy)ethyl]pyrazol-4-yl]-N-[8-amino-6-(2-methylphenyl)-2,7-naphthyridin-3-yl]cyclopropane-1-carboxamide?
(1S,5R)-N-[8-amino-6-(2-methylphenyl)-2,7-naphthyridin-3-yl]-3-(3-methoxyazetidin-1-yl)bicyclo[3.1.0]hexane-6-carboxamide;(1S,5R)-N-[8-amino-6-(2-methylphenyl)-2,7-naphthyridin-3-yl]-3-morpholin-4-ylbicyclo[3.1.0]hexane-6-carboxamide;trans-(1R,2R)-N-[8-amino-6-(2,6-dichlorophenyl)-2,7-naphthyridin-3-yl]-2-[1-[2-(2-aminoethoxy)ethyl]pyrazol-4-yl]cyclopropane-1-carboxamide;trans-(1S,2S)-N-[8-amino-6-(2,6-dichlorophenyl)-2,7-naphthyridin-3-yl]-2-[1-[2-(2-aminoethoxy)ethyl]pyrazol-4-yl]cyclopropane-1-carboxamide;trans-(1R,2R)-2-[1-[2-(2-aminoethoxy)ethyl]pyrazol-4-yl]-N-[8-amino-6-(2-methylphenyl)-2,7-naphthyridin-3-yl]cyclopropane-1-carboxamide has a molecular weight of 2411.52 g/mol, XLogP of 18.26, 36 rotatable bonds, 13 hydrogen bond donors, and 36 hydrogen bond acceptors.
Where does this data come from?
All data for (1S,5R)-N-[8-amino-6-(2-methylphenyl)-2,7-naphthyridin-3-yl]-3-(3-methoxyazetidin-1-yl)bicyclo[3.1.0]hexane-6-carboxamide;(1S,5R)-N-[8-amino-6-(2-methylphenyl)-2,7-naphthyridin-3-yl]-3-morpholin-4-ylbicyclo[3.1.0]hexane-6-carboxamide;trans-(1R,2R)-N-[8-amino-6-(2,6-dichlorophenyl)-2,7-naphthyridin-3-yl]-2-[1-[2-(2-aminoethoxy)ethyl]pyrazol-4-yl]cyclopropane-1-carboxamide;trans-(1S,2S)-N-[8-amino-6-(2,6-dichlorophenyl)-2,7-naphthyridin-3-yl]-2-[1-[2-(2-aminoethoxy)ethyl]pyrazol-4-yl]cyclopropane-1-carboxamide;trans-(1R,2R)-2-[1-[2-(2-aminoethoxy)ethyl]pyrazol-4-yl]-N-[8-amino-6-(2-methylphenyl)-2,7-naphthyridin-3-yl]cyclopropane-1-carboxamide is sourced from PubChem (CID 159579966), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).